Albany Molecular Research, Inc. (AMRI) Announces Fourth Quarter 2012 Adjusted EPS of $0.17

Published: Feb 12, 2013

ALBANY, N.Y., Feb. 12, 2013 -- /PRNewswire/ -- AMRI (Nasdaq: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2012.

Fourth Quarter:

•Adjusted earnings per share of $0.17, an increase of $0.36 from the prior-year period
•Contract revenue of $59.1 million, up 50% from the prior-year period with sequential revenue improvement in Discovery and Large Scale Manufacturing services

Back to news